Cargando…
PReS-FINAL-2198: Insufficient efficacy of tocilizumab therapy in children with Castleman's disease
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044530/ http://dx.doi.org/10.1186/1546-0096-11-S2-P188 |
| _version_ | 1782319161979961344 |
|---|---|
| author | Kozlova, A Abramov, D Miakova, N Maschan, A Shcherbina, A |
| author_facet | Kozlova, A Abramov, D Miakova, N Maschan, A Shcherbina, A |
| author_sort | Kozlova, A |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4044530 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2013 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-40445302014-06-19 PReS-FINAL-2198: Insufficient efficacy of tocilizumab therapy in children with Castleman's disease Kozlova, A Abramov, D Miakova, N Maschan, A Shcherbina, A Pediatr Rheumatol Online J Poster Presentation BioMed Central 2013-12-05 /pmc/articles/PMC4044530/ http://dx.doi.org/10.1186/1546-0096-11-S2-P188 Text en Copyright © 2013 Kozlova et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Kozlova, A Abramov, D Miakova, N Maschan, A Shcherbina, A PReS-FINAL-2198: Insufficient efficacy of tocilizumab therapy in children with Castleman's disease |
| title | PReS-FINAL-2198: Insufficient efficacy of tocilizumab therapy in children with Castleman's disease |
| title_full | PReS-FINAL-2198: Insufficient efficacy of tocilizumab therapy in children with Castleman's disease |
| title_fullStr | PReS-FINAL-2198: Insufficient efficacy of tocilizumab therapy in children with Castleman's disease |
| title_full_unstemmed | PReS-FINAL-2198: Insufficient efficacy of tocilizumab therapy in children with Castleman's disease |
| title_short | PReS-FINAL-2198: Insufficient efficacy of tocilizumab therapy in children with Castleman's disease |
| title_sort | pres-final-2198: insufficient efficacy of tocilizumab therapy in children with castleman's disease |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044530/ http://dx.doi.org/10.1186/1546-0096-11-S2-P188 |
| work_keys_str_mv | AT kozlovaa presfinal2198insufficientefficacyoftocilizumabtherapyinchildrenwithcastlemansdisease AT abramovd presfinal2198insufficientefficacyoftocilizumabtherapyinchildrenwithcastlemansdisease AT miakovan presfinal2198insufficientefficacyoftocilizumabtherapyinchildrenwithcastlemansdisease AT maschana presfinal2198insufficientefficacyoftocilizumabtherapyinchildrenwithcastlemansdisease AT shcherbinaa presfinal2198insufficientefficacyoftocilizumabtherapyinchildrenwithcastlemansdisease |